It looks that way as far as the CFQ goes. I'm aware of this from the IAPT-LTC Full Implementation Guidance:
Both Chalder Fatigue Questionnaire and PHQ-9 are bolded.
"
Notes: Recovery, reliable improvement and reliable deterioration rate calculations should be based on the pair measures highlighted in bold. When the measure in bold in the middle column is missing, the recovery calculation is based on the combination of PHQ-9 and GAD-7, if this is different."
Also, from the IAPT Manual:
The measure in the third column is the Chalder Fatigue Questionnaire
"
Recovery, reliable improvement and reliable deterioration rate calculations should be based on the pair of measures highlighted in bold. When the measure in bold in the third column is missing, the recovery calculation is based on the combination of PHQ-9 and GAD7, if this is different."
Also:
"
6.2.2 IAPT-LTC and MUS outcome measures
To support the implementation of The Five Year Forward View for Mental Health, LTC and/or MUS data from participating IAPT providers will be collected before widespread rollout to all IAPT providers."
Roll-out is being implemented, so I'm not sure what this means for data collection. Although in practical terms it probably doesn't make much difference from an implementation perspective, I think Fibromyalgia is reported as a LTC, although it depends on the the IAPT document you read as to whether Fibromyalgia is described as MUS or a LTC.
From the MUS Positive Practice Guide:
"Membership of the IAPT Medically Unexplained Symptoms Evaluation Task and
Finish Group (2012-13):
View attachment 3601 View attachment 3602
I seem to recall it will be a dedicated section.